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Introduction
Inappropriate prescribing is the failure to provide the quality of 
care related to medication use that should be achieved in practice, 
and encompasses overprescribing, misprescribing, and under 
prescribing [1]. Inappropriate medicine use has been defined as that 
which poses greater risk of harms than benefits, especially when safer 
alternatives exist [2]. Elderly patients, in particular, are susceptible to 
the consequences of inappropriate prescribing, increasing the risk of 
adverse drug events and related morbidity and hospitalisations [3,4]. 
Patients recently discharged from hospital are also at increased risk of 
medication misadventure, as medication is often reviewed and changed 
during an admission, and poorly communicated with community 
practitioners [5]. The importance of accurate transfer of information 
across the whole surgical care pathway from preadmission to discharge, 
including information about medications, was highlighted in a study 
that reported communication failures led to patient morbidity and 
mortality [6]. The Australian Commission on Quality and Safety in 
Health Care has highlighted medication reconciliation, and the accurate 
transfer of information about medication as a national priority [7]. 
Within hospital, the medication chart provides a record of 
patient’s medication, instructions for safe medication supply and 
administration, and ensures patient access to medications as an 
inpatient. It is a communication tool between doctors, pharmacists and 
nurses about prescribing decisions, and is used as the primary source 
of information regarding medications, both during the inpatient stay 
and on discharge. An appropriate and accurate medication chart is 
essential, and unless prescribing errors are found and corrected early, 
they can lead to errors in supply and administration [8]. 
Pre admission clinic (PAC) at Princess Alexandra Hospital (PAH) 
is a multidisciplinary clinic, comprising of nurse, Resident Medical 
Officer (RMO), pharmacy and anaesthetic review. The pharmacy 
service in PAC was initiated in 1998, with the aim of improvement 
in the accuracy of information exchange as patients cross healthcare 
setting [9]. The benefits of pharmacy involvement in PAC on 
medication management and information transfer prior to admission 
and on discharge, and the associated risks of omissions of medications 
at these times, were highlighted as part of a randomised controlled trial 
[10].  Pharmacy in PAC is now a well-recognised role in Australia, with 
the Society of Hospital Pharmacists of Australia (SHPA) publishing a 
fact sheet on how pharmacists in PAC can contribute to better patient 
outcomes and quality of care [11]. 
Several countries have extended the prescribing of prescription 
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Abstract
Background: Current evidence to support non-medical prescribing is predominantly qualitative, with little 
evaluation of appropriateness. This study aims to evaluate the appropriateness of prescribing, and significance 
of omissions, from a doctor pharmacist collaborative prescribing model in an elective surgery pre admission clinic 
(PAC).
Method: A modified version of the Medication Appropriate Index (MAI) was developed, piloted and subsequently 
used by an expert panel, comprised of a surgeon, anaesthetist, clinical pharmacologist, pharmacist, resident medical 
officer (RMO) and clinical nurse. The tool was used to rate the appropriateness of prescribing of medications, and 
the significance of omissions in a 5% sample (N=19) of the total cohort from a randomised, controlled two arm trial 
of doctor-pharmacist collaborative prescribing.
Results: When reviewer assessments were combined, 32 out of 294 (10.9%) medications assessed for 
appropriateness in the control arm were classed as inappropriate, compared to 13 of 266 (4.9%) in the intervention 
arm. Out of 89 regular medications in the control arm, 25 (28%) were omitted from the medication charts, compared 
to 1 out of 55 (2%) in the intervention arm (p<0.001, fishers exact) On average, 52% of omissions in the control arm 
were judged to have potential for patient harm or ward inconvenience.
Conclusion: For the appropriateness of prescribing, overall results were similar between arms, as judged by 
individual panel members. Medication charts in the control arm contained significantly more omissions than in the 
intervention arm, a number of which were rated by the panel members as having the potential for patient harm or 
ward inconvenience.
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only medicines to health care professionals other than doctors, with 
the aim of increasing patients’ access and choice, and make best use of 
health professionals’ skills, whilst ensuring patient safety [12]. Health 
Workforce Australia has highlighted possible models of prescribing 
for non-medical health professionals within the Australian healthcare 
system [13,14]. However, there is a lack of evidence to support this 
model of care. Current literature is predominantly qualitative, with 
little in the way of evaluation of quality, safety or appropriateness of 
prescribing. A recent review suggested that acceptance of the model of 
care was mainly based on the perceived value to the healthcare system 
[15]. 
Aim of the Study
To use a validated national health performance framework to 
compare a collaborative pharmacist prescribing model with usual 
care, with regards to effectiveness (incorporating appropriateness), 
safety, responsiveness, continuity, accessibility and efficiency [16]. The 
hypothesis was that no difference exists between the models of care. 
Results so far have shown pharmacist prescribing is as good as usual 
care in safety and accuracy of medication charts, and appropriateness 
of venous thromboembolism (VTE) prophylaxis [17]. 
The significant difference in omissions of medications prompted 
further investigation in to the appropriateness of prescribing, and 
the significance of medications that had not been prescribed on to 
the National inpatient medication chart (NIMC). The aim of the data 
discussed in this paper to assess a ‘snapshot’ of the appropriateness 
of prescribing from a pilot study, and the potential health impact or 
ward inconvenience of omissions from the NIMC. If the methodology 
utilised in the pilot proves feasible and yields meaningful data, this 
study will provide guidance for future assessments of appropriateness 
of prescribing from collaborative non-medical prescribing studies. 
Ethics approval was obtained from the PAH Human Research Ethics 
Committee.
Materials and Methods
The main study was conducted between June to September 2009 in 
the surgical, multidisciplinary PAC at PAH, a 750 bed tertiary teaching 
hospital in Queensland.
All patients who attended PAC and could provide written, 
informed consent were considered for participation. Patients were 
excluded if they were under 18 years of age, unable to communicate 
due to language difficulties or undergoing day surgery. A previous 
audit in PAH PAC showed an error rate of 12% of orders [18]. Using 
an expected error rate of 8% in the intervention arm a sample size of 
932 orders per group was calculated to be required for a power of 80%. 
Assuming an average of 5 orders per patient, it was estimated that 200 
patients per arm would be required for the main study.
Intervention cohort
Patients were seen by a nurse, prescribing pharmacist, Resident 
Medical Officer (RMO) and anaesthetist. Patients were seen by the 
pharmacist before they were seen by the RMO to allow usual RMO 
duties and a countersignature of the pharmacist prescriptions, a site 
requirement. The pharmacist undertook all pharmacist duties as per 
usual care, as well as prescribing medications on the NIMC.
Control cohort
Patients were seen by all four health care professionals in clinic, as 
per usual care. Patients in the control arm were still seen by a pharmacist, 
for usual care duties of a medication history, which was documented in 
the PAC assessment form and on the front of the NIMC. There was no 
set order in the control arm, meaning the patient could see the RMO 
first. The prescribing of the NIMC was the responsibility of the RMO. 
Sample of patients for panel assessment of appropriateness
Intervention and control patients from the main study were 
stratified in to 5 groups, from the first patient recruited to the last 
patient, in blocks of 40. Microsoft Excel random number generator was 
used to pick 2 numbers from each stratified group, giving a total of 10 
patients (5%) from both arms. The rationale for the stratification was 
to enable a selection of patients from across the study timeline, and a 
selection of prescribers in the control arm, as the study spanned across 
two rotations of junior doctors. Patients identified in the medication 
history in PAC as not taking any medication were excluded, and another 
number was generated until a patient who was taking medication prior 
to admission was selected. One patient was subsequently removed from 
the control group, due to being lost to follow up from the main study.
Panel selection
The panel consisted of a number of different health professionals, 
recognising either their involvement in the care of surgical patients, 
prescribing expertise or both; a consultant anaesthetist, a consultant 
hepatobiliary surgeon, a consultant clinical pharmacologist, a senior 
pharmacist with previous PAC experience, a senior PAC nurse, and a 
RMO with previous surgical and PAC experience. All panel members 
were independent to the research team.
Medication appropriateness index
Previous studies assessing appropriateness of prescribing, 
including non-medical prescribing, have identified the Medication 
Appropriateness Index (MAI) as the most suitable tool with which to 
assess appropriateness in an acute setting, with good inter and intra 
rater variability [19]. The tool consists of a 10-item rating system; 
indication, effectiveness, dose, correct directions, practical directions, 
drug-drug interactions, drug-disease interactions, duplication, 
duration and cost. Amendments were made to the MAI for our study; 
items regarding duration of therapy and cost effectiveness were not 
considered applicable, due to the scope of the pharmacist’s prescribing 
being medications that the patient was already taking. Additional 
questions were added, as the MAI does not assess under prescribing. 
Our finalised tool contained two questions to assess whether there 
had been an omission, and the significance in terms of potential ward 
inconvenience and patient harm. With regards to appropriateness of 
prescribing, the final tool contained 8 items. The original three-point 
Likert scale was dichotomised to either appropriate or inappropriate, 
as the original midpoint (marginally appropriate) was considered too 
subjective, as per previous studies [19]. 
Five patients were piloted by one member of the research team 
and one panel member prior to the panel assessment to assess whether 
the modified MAI could be applied to the patients appropriately, and 
to gain a rough estimate of an average time per patient. Time was an 
important factor, as this determined the number of patients that could 
be reasonably assessed, taking in to consideration panel members’ 
availability. A member of the research team met with all panel members 
prior to the panel sittings to discuss the modified MAI. Agreement was 
reached that it would be an appropriate tool to assess appropriateness 
and significance of omissions.
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Assessment of prescribing and omissions
Panel members were provided with copies of patient’s PAC notes, 
including the medication history taken by the PAC pharmacist, and 
the NIMC. The panel was blinded as to whether the patients were 
control or intervention. There was a possibility that panel members 
may have been able to identify whether the patient was in the control 
arm or intervention arm from the handwriting of the prescriber, as 
they were provided with the original medication charts. However, this 
risk of bias was judged to be minimal due to the multiple prescribers 
in the control arm, and the patients being presented to the panel in 
a random order. Signatures were considered to be a more obvious 
risk to unblinding, and as such they were removed from the NIMC 
that was given to the panel members. Resources provided included 
the Australian Medicines Handbook (AMH), locally produced PAC 
medication guidelines containing recommendations for management 
of medications peri operatively, and individual consultant preferences 
obtained by clinic for management of certain groups of medications 
peri operatively, for example anticoagulants. The panel was convened 
for 2 sittings, and each individual panel member rated every medication 
prescribed on to the NIMC using the criteria set out by the amended 
MAI. An unintentional omission was defined as any medication from 
the medication history not prescribed on the medication chart, with no 
supporting documentation as to why. Omissions were noted and panel 
members rated each one as whether it had the potential for patient 
harm, ward inconvenience, or both. Due to clinical duties only three 
panel members, the surgeon, clinical pharmacologist and pharmacist 
were able to make both sittings, and review all 19 patients. The other 
three panel members were only able to make one of the 2 sittings and 
reviewed as many patients possible in that time.
Data analysis
A medication was scored zero, and classed appropriate, if none of 
the 8 items on the MAI was rated as inappropriate. A medication was 
given a score of 1, and classed inappropriate, if one or more of the 8 
items received a rating of inappropriate. Each panel member’s ratings 
were evaluated individually, and ratings from all 6 panel members 
were combined, by adding the number of inappropriate reviews 
together. This gave the total number of medications that were rated 
as inappropriately prescribed, from the total number of reviews of 
medications that were undertaken by the panel. All statistical analysis 
was conducted using Stata 11.2 (Stata Corp, College Station, Tx).
Categorical data was analysed by chi-square tests. When the value in 
any one cell was below ten a Fisher’s exact test was used as chi-square 
tests can become unreliable
A p-value of <0.05 was considered statistically significant for the 
total number of omissions and individual reviewer assessment of 
appropriateness of prescribing.
Results
The sample included 19 patients, resulting in 294 medication 
assessments for appropriateness for the control arm, and 266 for the 
intervention arm, from the entire panel.
The demographics of patients selected for the appropriateness 
panel assessment were similar to those of patients from the main study 
[17] (Table 1).
Appropriateness of prescribing
Based on individual reviewer’s assessments only one reviewer, the 
pharmacist, showed statistical significance, 6/61 medications assessed 
inappropriate in the control arm, compared to 0/54 in the intervention 
(p=0.029).
Reviewer assessments were combined by adding the results 
together, in an attempt to describe the overall appropriateness. Out 
of 294 medication assessments across the panel for appropriateness, 
32 (10.9%) of the medications prescribed in the control arm were 
classed inappropriate, when compared to 13 out of 266 (4.9%) in the 
intervention arm. 
From the entire panel, an average of 5.7% of reviews across both 
arms were judged as inappropriate, with a range of 0 – 18.8%. Nine of 
the 19 patients were judged as having no inappropriate prescribing, 4 
from the control arm and 5 from the intervention arm.
There was a 78% agreement between panel members on 
inappropriateness of prescribing.
Table 2 shows total medications reviewed by each panel member, 
and a breakdown of reasons why each reviewer thought an individual 
medication was prescribed inappropriately.
Omissions
There were significantly more omissions in the control arm, 
of which four panel members’ individual assessments showed 
significant numbers had the potential for either patient harm or ward 
inconvenience. Total unintentional medication omissions from the 
NIMC in the main study was significantly higher for control patients 
(31.5%) compared to intervention (1.2%) (p<0.001, chi-square). 
Omissions from the 5% sample of patients were reflective of these 
results. Out of 89 regular medications in the patients’ medication 
histories in the control arm, 25 (28%) were omitted from the NIMC, 
compared to 1 out of 55 (2%) in the control arm (p<0.001, exact). In 
the control group, all patients had at least one omission. The median 
number of omissions was 2, with a range between 1-7. When asked to 
assess the severity of omission, all the reviewers thought a percentage of 
the omissions had the potential for patient harm, ward inconvenience, 
or both. The lowest individual reviewer assessment was 40% and 
the highest 78%, with the average across the panel showing 52% of 
‡ mean [range]
† median [range]
*Regular medications are defined as medications prescribed with the intent to be 
taken on a regular basis 
#’PRN’ medications are defined as medications prescribed with the intent to be 
taken only when required
Table 1: Characteristics of Study Population.
Control Intervention Control Intervention
Main Study Sub Set
Total Patients 190 194 9 10
Age ‡ 57.6 [18-89] 55.8 [18-86] 73 [55-85] 58 [34-77]
Male (%) 58% 59% 67% 60%
*Regular Medications† 4[0-16] 3[0-18] 4 [2-13] 3 [1-10]
#When Required ‘PRN’ 
Medications† 2[0-7] 1[0-4] 2 [0-6] 0 [0-4]
Complementary and 
Alternative Medicines 
(CAM) †
(0)[0-9] (0)[0-6] (0)[0-7] (0)[0-1]
Over The Counter (OTC) 
Medications† (0)[0-2] (0)[0-2] (0)[0-1] (0)[0-1]
Total Medications 1364 983 89 56
Total medications (regular 
and prn only) 1217 887 - -
Medication Charts 
Prescribed 161 (85%) 194 (100%) - -
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omissions in the control arm were assessed as having the potential for 
patient harm or ward inconvenience (Figure 1). Only one reviewer 
thought the omission in the intervention arm was significant.
Difference of opinion regarding significance of an omission is 
inevitable, some of the examples of omissions that were rated as 
‘potential for harm’ by all reviewers were; omission of aspirin from 
the medication chart in two patients, one of whom had a previous 
cerebrovascular accident (CVA) in 1995, and one of whom had a 
history of ischaemic heart disease (IHD); omission of esomeprazole 
40 mg from the medication chart of a patient who suffered from 
chronic gastro-oesophogeal reflux disease (GORD), and omission of 
perindopril 2.5 mg daily in a patient diagnosed with hypertension. 
Discussion
Our study showed that the appropriateness of prescribing from 
a collaborative doctor – pharmacist approach to prescribing was 
similar to usual care prescribing, and produced medication charts that 
contained significantly fewer omissions of relevant medications. 
Previous interventions to improve the appropriateness of 
prescribing have included an increase in clinical pharmacy involvement 
during the inpatient stay, which improved the prescribing of medicines 
[20,21]. Since the introduction of non-medical prescribing in UK, 
studies of appropriateness where nurses and pharmacists have taken 
on the prescribing role have shown that nurse and pharmacists were 
making clinically appropriate prescribing decisions [19,22]. 
There are various methods and tools in the literature to assess the 
appropriateness of prescribing, each with their own limitations [23,24]. 
The method chosen for our study was one of individual clinician, 
judgement based assessment. It has been suggested the results from 
this method may not always be valid, reproducible or generalisable. 
However, the same authors suggested that these limitations were 
remediable by using detailed specifications, validated instruments 
to obtain data and by training data collectors [1]. The use of the 
MAI satisfied all of these remedial criteria, although amongst the 6 
panel members differences of opinion as to the appropriateness of 
prescribing, or the significance of an omission is inevitable. Another 
approach could have been to ask the panel to use the MAI to rate each 
medication as a panel, rather than individually. The authors felt the 
issue of perceived seniority within the panel may have introduced bias 
in to the final decision, hence it was felt more reliable to ask each panel 
member to rate autonomously.
From Table 2, it can be seen that no one item from the assessment 
tool stood out as being the main reason why the prescribing was 
assessed as inappropriate across both arms. No indication, ineffective 
medications and duplication of medications can contribute to 
inappropriate polypharmacy, and increase the chance of medication 
misadventure [3]. Inappropriate doses and directions for medication 
increase the chance of incorrect administration of medication as an 
inpatient [11]. Omissions of medications from the inpatient medication 
chart, if not rectified during the inpatient stay, are likely to be omitted 
on any discharge information and summary as patients cross settings. 
This will expose the patient to an increased chance of poor outcomes, 
including unplanned 30 day readmission [9]. 
The study is limited by the small numbers of patients assessed by 
the panel for appropriateness of prescribing, and the inability of the 
entire panel to review all the patients, due to time constraints. One 
of the recognised limitations of the MAI is that it is time consuming, 
however it was considered the best tool for the clinical setting in which 
the study was conducted. Panel members’ availability and the amount 
of time deemed reasonable for members to commit to the panel 
amongst other clinical commitments, limited the number of patients 
that it was possible to assess, which affected the statistical power of the 
study, and the ability to assess rater variability. Future studies should 
bear in mind the requirement for all panel members to see all patients, 
to ensure consistency in the numbers of medications reviewed by each 
panel member.
The summing of the individual reviewer assessments to describe 
overall appropriateness would be flawed in the event of a panel not 
agreeing on what makes prescribing inappropriate. However, the use 
of an objective, validated tool with good inter rater variability was 
used to counteract that concern. Difference of opinion is inevitable, 
but our panel reached 78% agreement, with regards to inappropriate 
prescribing.
It can be challenging to link inappropriate prescribing to important 
outcome measures, such as mortality, morbidity and adverse drug 
events. However, from what is known on the subject of polypharmacy, 
and omissions of medication, there is little doubt that a review of 
medications on admission, a complete and accurate medication 
chart during the inpatient stay, and accurate transfer of information 
on discharge are all essential components of effective medication 
management and quality use of medicines [3,5,7,9]. 
A methodology had been developed that provides guidance for 
future assessments of the appropriate of prescribing in any study 
of non-medical prescribing. Results from this small snapshot of 
NB Medications may have been assessed as inappropriate for more than one reason, C = Control I = Intervention
Table 2: Number of Inappropriate Ratings and Reasons for Being Classed as Inappropriate by Reviewer (some data missing).
Reviewer Anaesthetist Pharmacologist Nurse Pharmacist RMO Surgeon
Number of Patients Reviewed 14 26 15 26 15 26
Medications Reviewed 77 110 73 115 68 117
Inappropriate Medications (%) 4 (5) 10 (9) 6 (8) 6 (5) 6 (9) 13 (11)
Reason C I C I C I C I C I C I
Medication Indicated 0 0 2 3 0 0 1 0 1 2 1 2
Medication Effective 0 0 1 3 0 0 1 0 0 1 1 1
Dose Correct 1 0 0 0 4 0 1 0 0 0 0 1
Directions Correct 2 0 0 0 3 0 0 0 2 0 2 2
Directions Practical 0 0 0 0 0 0 0 0  0 0 1 2
Drug–Drug Interaction 0 0 3 0 4 0 3 0 0 0 1 0
Drug–Disease Interaction 0 1 0 0 0 0 0 0 1 0 2 6
Duplication 0 0 4 0 2 0 1 0 0 0 2 0
Total 3 1 10 6 13 0 7 0 4 3 10 14
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prescribing are encouraging, and merit repeating the panel assessment 
on a larger scale. Larger numbers and more robust statistical analysis 
are necessary to enable any sound conclusions to be drawn, and for the 
results to be extrapolated and generalised outside of our small study.
Conclusion
For the appropriateness of prescribing, observed results were 
similar between arms, as judged by individual panel members. 
Medication charts in the control arm contained significantly more 
omissions than in the intervention arm, a number of which were rated 
by the panel members as having the potential for patient harm or ward 
inconvenience.
A larger sample size is required to make statistical significance or 
non-inferior conclusions between the two arms.
Acknowledgements
The authors would like to thank the following people for their involvement in 
the study:
Ms Ching-Ting Hung
Dr Thomas O’Rourke
Dr Elizabeth Maycock
Dr Gary Foo
Ms Elaine Brown
References
1. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane K, et al. (2007) 
Appropriate prescribing in elderly people: how well can it be measured and 
optimized? Lancet 370: 173-184.
2. Hamilton HJ, Gallagher PF, O’Mahony D (2009) Inappropriate prescribing and 
adverse drug events in older people. BMC Geriatr 9: 5.
3. Lund B, Carnahan R, Egge J, Chrischilles E, Kaboli P, et al. (2010) Inappropriate 
prescribing predicts adverse drug events in older adults. Ann Pharmacother 44: 
957-963.
4. Runciman W, Roughhead E, Semple S, Adams R (2003) Adverse drug events 
and medication errors in Australia. Int J Qual Healthcare 15: 49-59.
5. Mansur N, Weiss A, Beloosesky Y (2008) Relationship of in-hospital medication 
modifications of elderly patients to postdischarge medications, adherence, and 
mortality. Ann Pharmacother 42: 783-789.
6. Nagpal K, Arora S, Vats A, Wong H, Sevdalis N, et al. (2012) Failures in 
communication and information transfer across the surgical care pathway: 
interview study. BMJ Qual Saf 21: 843-849.
7. Australian Commission on Safety and Quality in Health Care. Medication 
Safety Action Guide. Australian Safety and Quality Goals for Health Care.
8. Stowasser D, Allinson Y, O’Leary K (2004) Understanding the medicines 
management pathway. J Pharm Pract Res 34: 293–296.
9. Stowasser D. Medication information and health outcomes – Development 
and evaluation of a medication liaison service. Thesis submitted for Doctor of 
Philosophy UQ Feb 2000.
10. Stowasser D, Collins M, Stowasser M (2002) A randomised controlled trial of 
medication liaison services-patient outcomes. Journal of Pharmacy Practice 
and Research 32: 133-140.
11. Society of Hospital Pharmacists of Australia. Medication assessment at pre 
admission for elective surgery. March 2012. Available from http://www.shpa.
org.au/scripts/cgiip.exe/WService=SHPA/ccms.r?PageId=18
12. Department of Health. Improving patients’ access to medicines: A guide to 
implementing nurse and pharmacist independent prescribing within the NHS 
in England. 12 April 2006.
13. Health Workforce Australia, HWA Work Plan 2011/12. Approved by Australian 
HealthMinisters’ Conference, 26 September 2011.
14. National Health Workforce Research and Planning Collaboration, Non-Medical 
Prescribing. (2010) An exploration of likely nature of, and contingencies for, 
developing a nationally consistent approach to prescribing by non-medical 
health professionals.
15. Bhanbhro S, Drennan V, Grant R, Harris R (2011) Assessing the contribution 
of prescribing in primary care by nurses and professionals allied to medicine: a 
systematic review of the literature.BMC Health Serv Res 11: 330
16. National Health Information Standards and Statistics Committee (NHISSC) 
2009. The National Health Performance Framework (2ndedn).
17. Hale AR, Coombes ID, Stokes J, McDougall D, Whitfield K, et al. (2013) 
Perioperative medication management: expanding the role of the preadmission 
clinic pharmacist in a single centre, randomised controlled trial of collaborative 
prescribing. BMJ Open 3:e003027.
18. Hale A, Nissen L (2010) Does the Consultation Order in a Multidisciplinary 
Elective Surgical Pre-Admission Clinic Influence the Frequency and Quality 
Harm &
inconvenience
Surgeon n=26
Pharmacist n=26
Pharmacologist
n=26
Nurse n=15
Anaesthetist n=14
0                  20                 40                60                 80                100
% of omissions rated
RMO n=15
Patient
harm alone
Inconvenience
alone
Neither inconvenience
nor harm
Figure 1: Panel Assessment of Significance of Omissions from Control Arm Medication Charts.
Citation: Hale A, Martin J, Coombes I, Mc Dougall D, Coombes J, et al. (2014) A Pilot Study to Assess the Appropriateness of Prescribing From a 
Collaborative Pharmacist Prescribing Study in a Surgical Pre Admission Clinic. J Pharma Care Health Sys 1: 110. doi:10.4172/jpchs.1000110
Page 6 of 6
Volume 1 • Issue 3 • 1000110
J Pharma Care Health Sys
ISSN: jpchs, an open access journal 
of Prescribing for Inpatient Medication Charts? Australasian Pharmaceutical 
Science Association, Brisbane.
19. Latter S, Maben J, Myall M, Young A (2007) Evaluating the clinical 
appropriateness of nurses’ prescribing practice: method development and 
findings from an expert panel analysis. Qual Safe Health Care 16: 415-421.
20. Spinewine A, Dhillon S, Mallett L, Tulken P, Wilmotte L, et al. (2006) 
Implementation of Ward-Based Clinical Pharmacy Services in Belgium—
Description of the Impact on a Geriatric Unit.Ann Pharmacother 40: 720-728.
21. Davis R, Hepfinger C, Sauer K, Wilhardt M (2007) Retrospective evaluation 
of medication appropriateness and clinical pharmacist drug therapy 
recommendations for home-based primary care veterans. Am J Geriatric 
Pharmacother 5: 40-47.
22. Department of Health Policy research Program Project 016 0108. Evaluation 
of pharmacist and nurse independent prescribing. Final Report October 2010.
23. Hanlon J, Schmader K, Samsa G, Weinberger M, Uttech K, et al. (1992) A 
method for assessing drug therapy appropriateness. J Clin Epidemiol 45: 
1045–1051.
24. Gallagher P, O’Connor M, O’Mahony D (2011) Prevention of Potentially 
Inappropriate Prescribing for Elderly Patients: A Randomized Controlled Trial 
Using STOPP/START Criteria. Clin Pharmacol &Ther  89: 845–854.
Submit your next manuscript and get advantages of OMICS 
Group submissions
Unique features:
•	 User	friendly/feasible	website-translation	of	your	paper	to	50	world’s	leading	languages
•	 Audio	Version	of	published	paper
•	 Digital	articles	to	share	and	explore
Special features:
•	 350	Open	Access	Journals
•	 30,000	editorial	team
•	 21	days	rapid	review	process
•	 Quality	and	quick	editorial,	review	and	publication	processing
•	 Indexing	at	PubMed	(partial),	Scopus,	EBSCO,	Index	Copernicus	and	Google	Scholar	etc
•	 Sharing	Option:	Social	Networking	Enabled
•	 Authors,	Reviewers	and	Editors	rewarded	with	online	Scientific	Credits
•	 Better	discount	for	your	subsequent	articles
Submit	your	manuscript	at:	http://www.scholarscentral.com/
Citation: Hale A, Martin J, Coombes I, Mc Dougall D, Coombes J, et al. (2014) 
A Pilot Study to Assess the Appropriateness of Prescribing From a Collaborative 
Pharmacist Prescribing Study in a Surgical Pre Admission Clinic. J Pharma 
Care Health Sys 1: 110. doi:10.4172/jpchs.1000110
